Prof. Dan Aderka of the Sheba Medical Center discusses the Optimal Sequence of Targeted Agents for All RAS & BRAF Patient Sub-types; Latest Data Update and Clinical Experience.
Prof. Dan Aderka @SHEBA_ #Virtual-GI20 #ColorectalCancer #Cancer #Research Optimal Sequence of Targeted Agents for All RAS & BRAF Patient Sub-types
By Editor